Therapeutic Drug Monitoring and Population Pharmacokinetic Analysis of Teicoplanin among Chinese Patients with Gram-Positive Infections in a Tertiary Hospital

被引:0
|
作者
Li, Yuan-Yuan [1 ,2 ]
Zhang, Guan-Xuan-Zi [1 ,2 ]
Wang, Jin [1 ]
Bai, Nan [1 ]
Cai, Yun [1 ]
机构
[1] Peoples Liberat Army Gen Hosp, Med Supplies Ctr, Ctr Med Clin Res, Dept Pharm, Beijing, Peoples R China
[2] PLA Med Sch, Beijing, Peoples R China
关键词
GUIDELINES; EFFICACY; SAFETY;
D O I
10.1155/2023/2681979
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background. To explore the use of teicoplanin among Chinese patients with Gram-positive infections in a tertiary hospital. Methods. The medical records of patients, who were monitored for teicoplanin plasma concentration (TPC) from December 2017 to February 2019, were collected. By combining the therapeutic drug monitoring (TDM) and nonlinear mixed-effects model, a population pharmacokinetic (PPK) model of teicoplanin was established. Results. The proportions of TPCs lower and higher than 10 mg/L were nearly the same (102 vs. 108 cases). A two-compartment model of teicoplanin PPK in Chinese patients was established. Compared with 400 mg, the 600 mg regimen was more able to reach the target concentration (10 mg/L), especially for high-weight patients. Conclusions. The standard regimen of teicoplanin, 400 mg, failed to reach the target value in the present population. Moreover, the 600 mg regimen was feasible for high-weight patients based on TDM and individualized pharmacokinetic dosing adjustment.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Therapeutic drug monitoring of linezolid in Chinese premature neonates: a population pharmacokinetic analysis and dosage optimization
    Duan, Lu-fen
    Li, Jing-jing
    Shen, Li-rong
    Chen, Xiang-long
    Yu, Yan-xia
    Yang, Zu-ming
    Zhang, Qian
    Cai, Yan
    Li, Jia-hui
    Wu, Juan
    Zhao, Han-zhen
    Xu, Jin-hui
    Feng, Zong-tai
    Tang, Lian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (11)
  • [22] Retrospective evaluation of teicoplanin dosing, therapeutic drug monitoring practices and target attainment in a Belgian tertiary hospital
    Buyle, F. M.
    Van de Wall, J.
    Claus, B.
    Vogelaers, D.
    De Cock, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 263 - 264
  • [23] Population Pharmacokinetic Analysis for Model-Based Therapeutic Drug Monitoring of Tacrolimus in Chinese Han Heart Transplant Patients
    Cheng, Yu
    Chen, Jiana
    Lin, Xiaojuan
    Qiu, Hongqiang
    Zhang, Jinhua
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (01) : 89 - 100
  • [24] Population Pharmacokinetic Analysis for Model-Based Therapeutic Drug Monitoring of Tacrolimus in Chinese Han Heart Transplant Patients
    Yu Cheng
    Jiana Chen
    Xiaojuan Lin
    Hongqiang Qiu
    Jinhua Zhang
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 89 - 100
  • [25] Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study
    Ljungman, P
    Hagglund, H
    Bjorkstrand, B
    Lonnqvist, B
    Ringden, O
    SUPPORTIVE CARE IN CANCER, 1997, 5 (06) : 485 - 488
  • [26] TEICOPLANIN - A WELL-TOLERATED AND EASILY ADMINISTRATED ALTERNATIVE TO VANCOMYCIN FOR GRAM-POSITIVE INFECTIONS IN INTENSIVE-CARE PATIENTS
    CHARBONNEAU, P
    HARDING, I
    GARAUD, JJ
    AUBERTIN, J
    BRUNET, F
    DOMART, Y
    INTENSIVE CARE MEDICINE, 1994, 20 : S35 - S42
  • [27] Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study
    P. Ljungman
    H. Hägglund
    B. Björkstrand
    B. Lönnqvist
    O. Ringdén
    Supportive Care in Cancer, 1997, 5 : 485 - 488
  • [28] Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
    Rodriguez-Gascon, Alicia
    Aguirre-Quinonero, Amaia
    Aspiazu, Maria Angeles Solinis
    Canut-Blasco, Andres
    ANTIBIOTICS-BASEL, 2021, 10 (07):
  • [30] Validation of a pharmacokinetic model for Bayesian therapeutic drug monitoring of teicoplanin administered by subcutaneous route in elderly patients
    Nicolas, A. S.
    Bourguignon, L.
    Percevault, S.
    Venisse, N.
    Mimoz, O.
    Maire, P.
    Ducher, M.
    Cazaubon, Y.
    Goutelle, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 25 - 25